Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2003

View Archived Issues

New alpha2delta ligands and their use reported by Pfizer

Indian scientists prepare and test new antimalarial trioxanes

Eisai patent covers new hemiasterlin analogues for cancer therapy

New antitumor compounds identified at Welichem

Janssen claims radiolabeled mGluR1 ligands for diagnostic uses

New p38 kinase inhibitors prepared and tested by Roche team

Abbott researchers describe new protein kinase inhibitors, their preparation and use

Merck scientists discover novel DPP-IV inhibitors for type 2 diabetes and other uses

Oral topoisomerase I inhibitor added to Novartis pipeline

Avigen files AV-201 IND

BTG obtains rights to three Sankyo Alzheimer's disease drugs

NDA accepted for antiinflammatory-antibiotic combination product

Positive animal data reported for Alvair

GH-9001 enters phase Ib trials in U.K.

SCD-HeFT study closes patient follow-up phase

Viramidine heads for late-stage clinical testing

Nippon Shinyaku grants Apogepha European rights for NS-8

Nitroglycerin lingual spray produces positive changes in hemodynamic endpoints

Pain Therapeutics developing Remoxy to deter oxycodone abuse

Shionogi and Hokkaido University enter novel glycoprotein research agreement

AZD-3582 associated with better intestinal tolerance compared to naproxen

DA-9601 provides high-quality ulcer healing in experimental rat model

Quinoxalinecarboxylic acid-based AMPA receptor antagonists with neuroprotective efficacy

Antiestrogen fulvestrant prevents gallstone formation

Itopride reduces esophageal acid exposure in GERD

Interferon gamma-1b reduces the duration of hospitalizations for IPF

Troxacitabine safety and efficacy in CML-BP

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.